Science & Medicine

AZD9291 for Acquired Resistance in EGFR Positive Lung Cancer

GRACEcast by Howard (Jack) West, MD

Jun 24, 201411:36Science & Medicine

EGFR positive lung cancer patients who had seen cancer progression responded well to a new drug in an early clinical trial.

About This Episode

AZD9291 for Acquired Resistance in EGFR Positive Lung Cancer is an episode from GRACEcast by Howard (Jack) West, MD. EGFR positive lung cancer patients who had seen cancer progression responded well to a new drug in an early clinical trial....

Podcast

This episode belongs to GRACEcast.

Listen Online

Use the player on this page to stream the episode online.

Episode Details

Published Jun 24, 2014, 11:36 long, audio available.

AZD9291 for Acquired Resistance in EGFR Positive Lung Cancer

About This Episode

Related Episodes